Gainesville, FL, United States of America

Russell Macoon

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Russell Macoon: Innovator in Retinal Drug Delivery

Introduction

Russell Macoon is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of ophthalmology, particularly in the area of drug delivery systems for retinal treatments. With a total of 3 patents to his name, Macoon's work is paving the way for advancements in medical technology.

Latest Patents

Macoon's latest patents include innovative devices and methods for intravitreal injection of substances. One of his key inventions is an auto-injector device designed for the injection of ophthalmological formulations. This device operates in two stages, first releasing a lubricious material and then delivering a drug composition. Additionally, he has developed methods and compositions for retinal drug delivery, focusing on extended release of drugs in the retina. These methods aim to enhance the effectiveness of therapeutic agents through intravitreal injection.

Career Highlights

Russell Macoon is affiliated with the University of Florida Research Foundation, Incorporated. His work has been instrumental in advancing the field of retinal drug delivery, showcasing his commitment to improving patient outcomes through innovative technology.

Collaborations

Macoon has collaborated with notable colleagues, including Anuj Chauhan and Keith G Christopher. These partnerships have contributed to the development of his groundbreaking inventions.

Conclusion

Russell Macoon's contributions to retinal drug delivery through his innovative patents highlight his role as a leading inventor in the field. His work continues to inspire advancements in ophthalmological treatments, ultimately benefiting patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…